Sale!

5-Fluorouracil (5-FU) Toxicity Test

Original price was: $376.Current price is: $250.

-34%

The 5-Fluorouracil (5-FU) Toxicity Test is a crucial pharmacogenomic analysis that identifies genetic variations in the DPYD gene, which plays a vital role in metabolizing 5-FU chemotherapy drugs. This test helps predict patients’ risk of developing severe, potentially life-threatening toxicities before starting cancer treatment. By analyzing specific gene mutations, healthcare providers can personalize chemotherapy dosing or consider alternative treatments, significantly improving patient safety and treatment outcomes. The test provides essential information for oncologists to make informed decisions about 5-FU-based chemotherapy regimens. Available for $250 USD, this molecular diagnostic test represents a proactive approach to cancer care management and medication safety.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

5-Fluorouracil (5-FU) Toxicity Test: Personalized Cancer Treatment Safety

Understanding 5-FU Toxicity Testing

The 5-Fluorouracil (5-FU) Toxicity Test represents a groundbreaking advancement in personalized cancer medicine, offering crucial insights into how individual patients may respond to one of the most commonly prescribed chemotherapy drugs worldwide. This pharmacogenomic test analyzes genetic variations that significantly impact drug metabolism and toxicity risk, enabling healthcare providers to deliver safer, more effective cancer treatment.

What This Test Measures and Detects

This comprehensive molecular diagnostic test specifically examines variations in the DPYD (dihydropyrimidine dehydrogenase) gene, which encodes the primary enzyme responsible for metabolizing 5-fluorouracil and related fluoropyrimidine drugs. The test identifies:

  • DPYD gene polymorphisms associated with reduced enzyme activity
  • Specific genetic variants that predict severe toxicity risk
  • Individual metabolic capacity for 5-FU breakdown
  • Genetic markers for dose adjustment requirements

Who Should Consider This Test

This test is particularly important for patients who are candidates for 5-FU-based chemotherapy regimens, including those with:

  • Colorectal cancer requiring FOLFOX or FOLFIRI regimens
  • Breast cancer treatment plans involving fluoropyrimidines
  • Head and neck cancers treated with 5-FU combinations
  • Gastrointestinal malignancies
  • Patients with family history of severe chemotherapy reactions

Recognizing Potential Risk Factors

Patients experiencing or at risk for these symptoms during 5-FU treatment should consider testing:

  • Severe neutropenia and bone marrow suppression
  • Life-threatening diarrhea and gastrointestinal toxicity
  • Mucositis and oral ulcerations
  • Hand-foot syndrome (palmar-plantar erythrodysesthesia)
  • Unexpected neurological complications

Benefits of 5-FU Toxicity Testing

Undergoing this pharmacogenomic analysis provides numerous advantages for both patients and healthcare providers:

  • Personalized Treatment Planning: Enables customized chemotherapy dosing based on genetic profile
  • Reduced Toxicity Risk: Identifies patients at high risk for severe adverse effects before treatment begins
  • Improved Safety: Helps prevent life-threatening complications from standard chemotherapy doses
  • Enhanced Treatment Efficacy: Optimizes drug exposure while minimizing toxicity
  • Cost-Effective Care: Reduces hospitalizations and supportive care needs

Understanding Your Test Results

Your test results will provide valuable information about your DPYD gene status and its implications for 5-FU chemotherapy:

Normal DPYD Function

Patients with normal DPYD gene variants typically metabolize 5-FU efficiently and can generally tolerate standard chemotherapy doses with expected side effect profiles.

Intermediate Metabolizer Status

Individuals with certain DPYD variants may require dose reductions of 25-50% to prevent excessive toxicity while maintaining treatment effectiveness.

Poor Metabolizer Status

Patients identified as poor metabolizers have significantly reduced ability to break down 5-FU and are at high risk for severe, potentially fatal toxicity. Alternative treatment regimens are strongly recommended.

Test Pricing and Availability

Test Name Regular Price Discount Price
5-Fluorouracil (5-FU) Toxicity Test $376 USD $250 USD

Test Specifications

  • Turnaround Time: 1 week
  • Sample Type: 4 mL (2 mL min.) whole blood from 1 Lavender Top (EDTA) tube
  • Shipping Instructions: Ship refrigerated. DO NOT FREEZE
  • Required Documentation: Duly filled Genomics Clinical Information Requisition Form (Form 20)
  • Test Methodology: PCR and Sequencing
  • Specialty: Oncologist
  • Department: Molecular Diagnostics

Nationwide Testing Availability

We have branches across the United States, making this essential test accessible to patients nationwide. Our testing facilities are conveniently located in major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Each location maintains the same high standards of laboratory excellence and patient care.

Take Control of Your Cancer Treatment Safety

Don’t leave your chemotherapy safety to chance. The 5-FU Toxicity Test provides critical genetic information that can significantly impact your treatment experience and outcomes. By understanding your individual risk profile, you and your healthcare team can make informed decisions about your cancer care journey.

Ready to schedule your test? Contact our dedicated patient care team today at +1(267) 388-9828 or book your appointment online. Our genetic counselors and oncology specialists are available to answer your questions and guide you through the testing process.

Take the first step toward personalized, safer cancer treatment. Book your 5-Fluorouracil Toxicity Test today and empower yourself with knowledge that could save your life.